Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety Article

Open Access Industry Collaboration International Collaboration

cited authors

  • Oaknin, Ana; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne, I; Clamp, Andrew R.; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Amenedo Gancedo, Margarita; Fong, Peter C.; Goh, Jeffrey C.; O'Malley, David M.; Armstrong, Deborah K.; Banerjee, Susana; Garcia-Donas, Jesus; Swisher, Elizabeth M.; Cameron, Terri; Maloney, Lara; Goble, Sandra; Ledermann, Jonathan A.; Coleman, Robert L.

authors

Publication Date

  • September 21, 2021

webpage

published in

category

keywords

  • clinical trials
  • gynecological oncology
  • medical oncology
  • target therapy
  • women's cancer

start page

  • 7162

end page

  • 7173

volume

  • 10

issue

  • 20